TY - JOUR AU - Treshchinskaia, M.A. AU - Kononov, O.Ye. AU - Belskaia, I.V. PY - 2021/11/15 Y2 - 2024/03/29 TI - Pathogenetically substantiated prevention of cerebrovascular disorders in patients with coronavirus disease JF - INTERNATIONAL NEUROLOGICAL JOURNAL JA - INJ VL - 16 IS - 7 SE - Original Researches DO - 10.22141/2224-0713.16.7.2020.218243 UR - https://inj.zaslavsky.com.ua/index.php/journal/article/view/835 SP - 23-31 AB - <p>The paper deals with the basic pathogenic mechanisms of thrombosis development both arterial and venous in patients with COVID-19. These patients developed critical complications in cases of vascular risk factors that significantly enhances the risk of occurrence of such vascular events as acute ischemic stroke. The thrombophilia mechanism in a patient with COVID-19 disease turns on the direct activation of coagulation, so antiplatelet drugs cannot prevent the development of thrombosis while the vascular risk factors and prominent inflammatory reaction cause vascular events. The optimization of antiplatelet therapy in patients with <br />COVID-19 disease with vascular risk factors is relevant. Triflusal is an antiplatelet drug with the best characteristics for the treatment of these patients.</p> ER -